BN
Bilge, Nuray
25 papers · 56 citations · 2021–2026
Publications
25
Citations
56
Years
6
Publications
| Title | Year | Type | Citations |
|---|---|---|---|
|
Restless Leg Syndrome and Association with Serum NT Pro-CNP
|
2026 | Article | 0 |
|
Demographic, Clinical, and Radiological Characteristics of Familial Multiple Sclerosis: A Multicenter Retrospective Study from Turkiye
|
2025 | Meeting Abstract | 0 |
|
Intimate Partner Violence in Multiple Sclerosis: Patterns, Predictors, and Attitudinal Dimensions in a Multicenter Cohort
|
2025 | Meeting Abstract | 0 |
|
MS Plus: A Comprehensive Assessment of the Frequency and Clinical-Serological Profile of Coexisting Rheumatologic Diseases in Multiple Sclerosis
|
2025 | Meeting Abstract | 0 |
|
Epstein-Barr Virus miRNAs in Multiple Sclerosis: Unveiling their role in Immune Regulation and Potential for Diagnostic and Therapeutic Innovation
|
2025 | Article | 0 |
|
Impact of age at onset on diagnosis, treatment, and prognosis in pediatric-onset multiple sclerosis: A multicenter study from Turkey
|
2025 | Article | 0 |
|
Comparative efficacy of rituximab versus azathioprine in the treatment of MOG antibody-associated disease (MOGAD)
|
2025 | Article | 1 |
|
The role of oligoclonal band count and IgG index in treatment response and disease activity in multiple sclerosis (vol 83,105391,2024)
|
2025 | Correction | 0 |
|
Serum endocan levels in patients with multiple sclerosis
|
2025 | Meeting Abstract | 0 |
|
Impulsivity and attention deficit-hyperactivity symptoms among patients with relapsing-remitting multiple sclerosis: a case-control study
|
2024 | Article | 3 |
|
The Impact of Multiple Sclerosis on Marriage and Divorce: Insights from A Multicenter Study in Turkey
|
2024 | Meeting Abstract | 0 |
|
Clinical, Demographic, and Radiological Characteristics of Patients Demonstrating Antibodies Against Myelin Oligodendrocyte Glycoprotein
|
2024 | Article | 2 |
|
The role of oligoclonal band count and IgG index in treatment response and disease activity in multiple sclerosis
|
2024 | Article | 7 |
|
Partial Regression of Thymoma With the Treatment of Myasthenia Gravis
|
2023 | Editorial Material | 1 |
|
Immune responses following COVID-19 infection in multiple sclerosis patients using immunomodulatory therapy
|
2023 | Article | 1 |
|
Effect of Online Learning During the COVID-19 Pandemic on Tension-Type Headache, and Anxiety Among Medical Students
|
2023 | Article | 1 |
|
Vaccination in Individuals with Multiple Sclerosis - Part I
|
2023 | Review | 1 |
|
Vaccination in Individuals with Multiple Sclerosis - Part II
|
2023 | Review | 3 |
|
Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment (vol 60, pg 23, 2023)
|
2023 | Correction | 0 |
|
Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment
|
2023 | Article | 4 |
|
Vitamin D levels and C-reactive protein/albumin ratio in pregnant women with cerebral venous sinus thrombosis
|
2022 | Article | 5 |
|
Low serum osteopontin levels in individuals with choroid plexus calcification
|
2022 | Article | 0 |
|
Favipiravir Experience in Covid-19 Positive Myasthenia Gravis Patients
|
2021 | Letter | 1 |
|
Expression levels of IL-17/IL-23 cytokine-targeting microRNAs 20, 21, 26, 155, and Let-7 in patients with relapsing-remitting multiple sclerosis
|
2021 | Article | 16 |
|
Low serum A-SYNUCLEIN and oligomer A-SYNUCLEIN levels in multiple sclerosis patients
|
2021 | Article | 10 |